ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01625234
Brief Title: Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer

First Submitted : June 15, 2012
First Submitted that Met QC Criteria : June 18, 2012
First Posted : June 21, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : July 12, 2018
Last Update Posted : July 16, 2018